Stock 9969 INNOCARE PHARMA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Revisions InnoCare Pharma Limited

Equities

9969

KYG4783B1032

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:58 2024-07-11 am EDT 		5-day change 1st Jan Change
4.81 HKD +3.44% Intraday chart for InnoCare Pharma Limited -0.82% -30.19%
Jun. 21 China Grants Priority Review Status for InnoCare's Lymphoma Drug; Shares Jump 6% MT
Jun. 20 InnoCare Pharma Announces the Acceptance of Biologics License Application for Tafasitamab in Combination with Lenalidomide for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma in Adult Patients in China CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. 9969 Stock
  4. Revisions InnoCare Pharma Limited